120 related articles for article (PubMed ID: 10555611)
1. Prognostic factors correlated with survival in AIDS patients.
Casari S; Donisi A; Paraninfo G; Tomasoni D; Palvarini L; Nasta P; Bergamasco A; Cadeo GP; Carosi G
Eur J Epidemiol; 1999 Sep; 15(8):691-8. PubMed ID: 10555611
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
4. The role of initial AIDS-defining illness in survival following AIDS.
Luo K; Law M; Kaldor JM; McDonald AM; Cooper DA
AIDS; 1995 Jan; 9(1):57-63. PubMed ID: 7893442
[TBL] [Abstract][Full Text] [Related]
5. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
7. Impact of opportunistic disease on survival in patients with HIV infection.
Chaisson RE; Gallant JE; Keruly JC; Moore RD
AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
[TBL] [Abstract][Full Text] [Related]
8. Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.
Grabar S; Lanoy E; Allavena C; Mary-Krause M; Bentata M; Fischer P; Mahamat A; Rabaud C; Costagliola D;
HIV Med; 2008 Apr; 9(4):246-56. PubMed ID: 18366449
[TBL] [Abstract][Full Text] [Related]
9. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
10. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
; Mocroft A; Sterne JA; Egger M; May M; Grabar S; Furrer H; Sabin C; Fatkenheuer G; Justice A; Reiss P; d'Arminio Monforte A; Gill J; Hogg R; Bonnet F; Kitahata M; Staszewski S; Casabona J; Harris R; Saag M
Clin Infect Dis; 2009 Apr; 48(8):1138-51. PubMed ID: 19275498
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with survival following secondary AIDS: 1988 to 1995.
Huang H; Chmiel JS; Detels R; Hoover DR; Muñoz A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):495-504. PubMed ID: 9715847
[TBL] [Abstract][Full Text] [Related]
12. Survival by AIDS defining condition in rural Uganda.
Morgan D; Malamba SS; Orem J; Mayanja B; Okongo M; Whitworth JA
Sex Transm Infect; 2000 Jun; 76(3):193-7. PubMed ID: 10961197
[TBL] [Abstract][Full Text] [Related]
13. Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992.
Barchielli A; Acciai S; Lazzeri V; Buiatti E
Eur J Epidemiol; 1997 Feb; 13(2):125-32. PubMed ID: 9084993
[TBL] [Abstract][Full Text] [Related]
14. [AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].
Zucchetto A; Bruzzone S; De Paoli A; Regine V; Pappagallo M; Dal Maso L; Serraino D; Rezza G; Suligoi B
Epidemiol Prev; 2009; 33(4-5):184-9. PubMed ID: 20124634
[TBL] [Abstract][Full Text] [Related]
15. AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.
Law MG; de Winter L; McDonald A; Cooper DA; Kaldor JM
AIDS; 1999 Feb; 13(2):263-9. PubMed ID: 10202833
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study Group.
Phillips AN; Lazzarin A; Gonzales-Lahoz J; Clumeck N; Glauser MP; Proenca R; Banhegyi D; Pedersen C; Lundgren JD; Johnson AM
J Clin Epidemiol; 1996 Nov; 49(11):1253-8. PubMed ID: 8892493
[TBL] [Abstract][Full Text] [Related]
17. A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Stebbing J; Sanitt A; Nelson M; Powles T; Gazzard B; Bower M
Lancet; 2006 May; 367(9521):1495-502. PubMed ID: 16679162
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia versus wasting syndrome among AIDS cases in Puerto Rico: a survival analysis.
Mayor Becerra AM; Suárez E; Morales Bedoya A
P R Health Sci J; 1996 Dec; 15(4):257-60. PubMed ID: 9097342
[TBL] [Abstract][Full Text] [Related]
20. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
